The influence of cetyltrimethyl ammonium bromide on electrochemical properties of thyroxine reduction at carbon nanotubes modified electrode.
The effect of cetyltrimethyl ammonium bromide (CTAB) on the electrochemical behaviors of thyroxine at a glassy carbon electrode (GCE) modified with single-walled carbon nanotubes (SWNTs) was investigated. At the SWNTs film-coated GCE, a well-defined oxidation peak of thyroxine at 0.78 V was obtained, but the reduction peak of thyroxine was indiscernible. When trace CTAB was added to the working solution, the reduction current could be greatly enhanced and the oxidation current remained stable. The reaction mechanisms for the reduction of thyroxine were explored by chronocoulometry. Thyroxine might form particular ion complex with CTAB via the interaction between iodine atoms on thyroxine and bromide ions in CTAB, which made the concentration of thyroxine at the surface of the modified electrode increased and the electron transfer rate enhanced. The proper mechanisms for the enhanced reduction of thyroxine in the present of CTAB were explored by several electrochemical techniques including cycle voltammetry linear sweep voltammetry and others. It was concluded that the special interactions between the thyroxine CTAB and SWNTs resulted in the increase of the reduction peak current. All results indicated that two iodine atoms on the thyroxine and four electrons were involved the reduction process which was irreversible and two iodine ions produced. In this system, the sensitive reduction peak of thyroxine at 0.3 V was employed to determine thyroxine and a low detection limit of 2x10(-8) mol/L was obtained for 2 min accumulation at 0.9 V. The SWNTs coated GCE had good stability and reproducibility.
Wang
Fang
F
Department of Chemistry, Wuhan University, Wuhan 430072, PR China.
Fei
Junjie
J
Hu
Shengshui
S
D001672:Biocompatible Materials; D002138:Calibration; D000077286:Cetrimonium; D002593:Cetrimonium Compounds / Q000737:chemistry / Q000494:pharmacology*; D004563:Electrochemistry / Q000379:methods*; D004566:Electrodes; D004583:Electrons; D006863:Hydrogen-Ion Concentration; D008956:Models, Chemical; D037742:Nanotubes, Carbon; D010100:Oxygen / Q000378:metabolism; D013499:Surface Properties; D013501:Surface-Active Agents / Q000737:chemistry / Q000494:pharmacology*; D013974:Thyroxine / Q000737:chemistry*; D013997:Time Factors
D001672:Biocompatible Materials; D002593:Cetrimonium Compounds; D037742:Nanotubes, Carbon; D013501:Surface-Active Agents; D013974:Thyroxine; D010100:Oxygen; D000077286:Cetrimonium